共 212 条
[1]
Abanades S(2011)Prediction of repeat-dose occupancy from single-dose data: characterization of the relationship between plasma pharmacokinetics and brain target occupancy J Cereb Blood Flow Metab 31 944-952
[2]
van der Aart J(1999)Reduced volume of limbic system-affiliated basal ganglia in mood disorders: preliminary data from a postmortem study J Neuropsychiatry Clin Neurosci 11 71-78
[3]
Barletta JA(2011)Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic Int J Clin Pract 65 189-210
[4]
Marzano C(1994)Performance characteristics of a whole-body PET scanner J Nuc Med 35 1398-1406
[5]
Searle GE(2010)Focus on lurasidone: a new atypical antipsychotic for the treatment of schizophrenia Formulary 45 313-317
[6]
Salinas CA(1985)Preparation of 11C-labelled Raclopride, a new potent dopamine receptor antagonist: preliminary PET studies of cerebral dopamine receptors in the monkey Int J Appl Radiat Isot 36 269-273
[7]
Ahmad JJ(1995)Positron emission tomography studies on D2 and 5-HT2 receptor binding in risperidone-treated schizophrenic patients J Clin Psychopharmacol 15 19S-23S
[8]
Reiley RR(2006)The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia Neuropsychopharmacol 31 1027-1035
[9]
Pampols-Maso S(2002)Strategies to improve neuroreceptor parameter estimation by linear regression analysis J Cereb Blood Flow Metab 22 1271-1281
[10]
Zamuner S(2007)Consensus nomenclature for in vivo imaging of reversibly binding radioligands J Cereb Blood Flow Metab 27 1533-1539